Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 2012. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific share transaction notification and does not contain financial performance data.
Material Changes
The filing details a specific acquisition of 9 Ordinary shares by Mrs. K Thomson, a connected person of Director Mr. P C Thomson. The shares were purchased on January 5, 2012, at a price of 1,478.363 pence per share. This transaction resulted from the reinvestment of dividends paid on shares held in the GlaxoSmithKline ShareReward Plan.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document strictly reports on the compliance notification of the share transaction under Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Facts for Investor Verification
- Transaction Date: January 5, 2012.
- Connected Person: Mrs. K Thomson (connected to Director Mr. P C Thomson).
- Transaction Type: Acquisition of 9 Ordinary shares via dividend reinvestment.
- Share Price: 1,478.363 pence per share.
- Notification Date: January 6, 2012.